Keyphrases
Morphine
100%
Antiangiogenic Therapy
100%
Pericyte-endothelial Interaction
100%
Platelet-derived Growth Factor Receptor (PDGFR)
44%
Platelet-derived Growth factor-BB (PDGF-BB)
33%
Tumor Angiogenesis
33%
Pericytes
22%
Pericyte Coverage
22%
Clinically Significant
11%
Transgenic Mouse Model
11%
Tumor
11%
Cancer Progression
11%
Receptor-interacting Protein Kinase 1 (RIPK1)
11%
Receptor Signaling
11%
Immunoreactivity
11%
Mitogen-activated Protein Kinase
11%
Human Umbilical Vein Endothelial Cells (HUVECs)
11%
Phosphorylated Extracellular Signal-regulated Kinase
11%
In Vitro Effect
11%
Desmin
11%
Tumor Vessels
11%
Tumor Cancer
11%
Vascular Pericytes
11%
Human Pericytes
11%
Mouse Breast Cancer
11%
Pericyte Recruitment
11%
Medicine and Dentistry
Antiangiogenic Therapy
100%
Morphine
100%
Pericyte
100%
Platelet Derived Growth Factor Receptor
44%
Tumor Angiogenesis
33%
Platelet Derived Growth Factor BB
33%
Neoplasm
22%
In Vitro
11%
Transgenic Mouse
11%
Breast Cancer
11%
Cancer Growth
11%
Secretion (Process)
11%
Immunoreactivity
11%
Human Umbilical Vein Endothelial Cell
11%
Protein Kinases
11%
Mitogen-Activated Protein Kinase
11%
Desmin
11%
Biochemistry, Genetics and Molecular Biology
Pericyte
100%
Platelet-Derived Growth Factor Receptor
66%
Platelet-Derived Growth Factor
50%
Angiogenesis
50%
Mouse Model
16%
Secretion (Process)
16%
Transgenic Mouse
16%
Extracellular Signal-Regulated Kinases
16%
Immunoreactivity
16%
Protein Kinases
16%
Desmin
16%